656 related articles for article (PubMed ID: 32428392)
1. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
[TBL] [Abstract][Full Text] [Related]
2. Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus.
Daczkowski CM; Goodwin OY; Dzimianski JV; Farhat JJ; Pegan SD
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931677
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
Ratia K; Kilianski A; Baez-Santos YM; Baker SC; Mesecar A
PLoS Pathog; 2014 May; 10(5):e1004113. PubMed ID: 24854014
[TBL] [Abstract][Full Text] [Related]
4. Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.
Rut W; Lv Z; Zmudzinski M; Patchett S; Nayak D; Snipas SJ; El Oualid F; Huang TT; Bekes M; Drag M; Olsen SK
Sci Adv; 2020 Oct; 6(42):. PubMed ID: 33067239
[TBL] [Abstract][Full Text] [Related]
5. Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease.
Clasman JR; Everett RK; Srinivasan K; Mesecar AD
Antiviral Res; 2020 Feb; 174():104661. PubMed ID: 31765674
[TBL] [Abstract][Full Text] [Related]
6. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
Báez-Santos YM; St John SE; Mesecar AD
Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
[TBL] [Abstract][Full Text] [Related]
7. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
Shin D; Mukherjee R; Grewe D; Bojkova D; Baek K; Bhattacharya A; Schulz L; Widera M; Mehdipour AR; Tascher G; Geurink PP; Wilhelm A; van der Heden van Noort GJ; Ovaa H; Müller S; Knobeloch KP; Rajalingam K; Schulman BA; Cinatl J; Hummer G; Ciesek S; Dikic I
Nature; 2020 Nov; 587(7835):657-662. PubMed ID: 32726803
[TBL] [Abstract][Full Text] [Related]
8. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
[TBL] [Abstract][Full Text] [Related]
9. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
10. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.
Ma C; Sacco MD; Hurst B; Townsend JA; Hu Y; Szeto T; Zhang X; Tarbet B; Marty MT; Chen Y; Wang J
Cell Res; 2020 Aug; 30(8):678-692. PubMed ID: 32541865
[TBL] [Abstract][Full Text] [Related]
11. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.
Patchett S; Lv Z; Rut W; Békés M; Drag M; Olsen SK; Huang TT
Cell Rep; 2021 Sep; 36(13):109754. PubMed ID: 34547223
[TBL] [Abstract][Full Text] [Related]
12. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
[TBL] [Abstract][Full Text] [Related]
13. Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species.
Daczkowski CM; Dzimianski JV; Clasman JR; Goodwin O; Mesecar AD; Pegan SD
J Mol Biol; 2017 Jun; 429(11):1661-1683. PubMed ID: 28438633
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19.
Clemente V; D'Arcy P; Bazzaro M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429099
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
Jin Z; Zhao Y; Sun Y; Zhang B; Wang H; Wu Y; Zhu Y; Zhu C; Hu T; Du X; Duan Y; Yu J; Yang X; Yang X; Yang K; Liu X; Guddat LW; Xiao G; Zhang L; Yang H; Rao Z
Nat Struct Mol Biol; 2020 Jun; 27(6):529-532. PubMed ID: 32382072
[TBL] [Abstract][Full Text] [Related]
16. Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease.
Békés M; van der Heden van Noort GJ; Ekkebus R; Ovaa H; Huang TT; Lima CD
Mol Cell; 2016 May; 62(4):572-85. PubMed ID: 27203180
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease.
Nayak D; Dos Santos Bury P; Drag M; Nijkerk AN; El Oualid F; Olsen SK
Methods Mol Biol; 2023; 2591():171-188. PubMed ID: 36350549
[TBL] [Abstract][Full Text] [Related]
18. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
Akaji K; Konno H
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
[TBL] [Abstract][Full Text] [Related]
19. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.
Fu L; Ye F; Feng Y; Yu F; Wang Q; Wu Y; Zhao C; Sun H; Huang B; Niu P; Song H; Shi Y; Li X; Tan W; Qi J; Gao GF
Nat Commun; 2020 Sep; 11(1):4417. PubMed ID: 32887884
[TBL] [Abstract][Full Text] [Related]
20. SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.
Békés M; Rut W; Kasperkiewicz P; Mulder MP; Ovaa H; Drag M; Lima CD; Huang TT
Biochem J; 2015 Jun; 468(2):215-26. PubMed ID: 25764917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
